Development code · Small Molecule

CPL'36

CPL'36 is a development code for Alofropodect, developed by Celon Pharma S.A..

Status
Phase 2 for Schizophrenia
Mechanism
PDE10A Inhibitor

Programs

Also known as

  • CPL500036
  • CPL-500036
  • CPL 500036
  • CPL36
  • alofropodect
  • 1829530-11-1
  • 5,8-dimethyl-2-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)-[1,2,4]triazolo[1,5-a]pyrazine

View the full Alofropodect profile →